IN8BIO, INC. Basic Shares Outstanding (Weighted Average)
IN8BIO, INC. (INAB) reported Basic Shares Outstanding (Weighted Average) of 19.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- IN8BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 19.47M shares, a 372.60% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 19.47M shares, a 655.91% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 7.10M shares, a 173.70% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 4.54M shares, a 187.68% increase year-over-year.
- IN8BIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 4.37M shares, a 145.08% increase from fiscal 2024.
- IN8BIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 1.78M shares, a 94.02% decline from fiscal 2023.
- IN8BIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 29.86M shares, a 42.43% increase from fiscal 2022.
- IN8BIO, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 20.97M shares, a 110.32% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.47M shares 10-Q · filed 2026-08-06 | 19.47M shares 10-Q · filed 2026-08-06 | 15.35M shares derived: average of 3 quarters · filed 2026-08-06 | 12.64M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 19.47M shares 10-Q · filed 2026-05-07 | 13.28M shares derived: average of 2 quarters · filed 2026-05-07 | 10.37M shares derived: average of 3 quarters · filed 2026-05-07 | 8.81M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 7.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 5.82M shares derived: average of 2 quarters · filed 2026-03-12 | 5.25M shares derived: average of 3 quarters · filed 2026-08-06 | 4.37M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 4.54M shares 10-Q · filed 2025-11-06 | 4.33M shares derived: average of 2 quarters · filed 2026-08-06 | 3.47M shares 10-Q · filed 2025-11-06 | 3.46M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 4.12M shares 10-Q · filed 2026-08-06 | 2.92M shares 10-Q · filed 2026-08-06 | 3.10M shares derived: average of 3 quarters · filed 2026-08-06 | 2.72M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 2.58M shares 10-Q · filed 2026-05-07 | 83.48M shares 10-Q · filed 2025-05-07 | 2.59M shares derived: average of 2 quarters · filed 2026-05-07 | 2.25M shares derived: average of 3 quarters · filed 2026-05-07 | 2.08M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 2.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 2.09M shares derived: average of 2 quarters · filed 2026-03-12 | 1.91M shares derived: average of 3 quarters · filed 2026-03-12 | 1.78M shares 10-K · filed 2026-03-12 | 53.55M shares 10-K · filed 2025-03-13 | |||
| 2024-09-30 | 1.58M shares 10-Q · filed 2025-11-06 | 47.32M shares 10-Q · filed 2024-11-12 | 1.57M shares derived: average of 2 quarters · filed 2025-11-06 | 1.51M shares 10-Q · filed 2025-11-06 | 45.69M shares 10-Q · filed 2024-11-12 | 20.27M shares derived: average of 4 quarters · filed 2025-11-06 | ||
| 2024-06-30 | 1.57M shares 10-Q · filed 2025-08-07 | 45.13M shares 10-Q · filed 2024-08-08 | 1.48M shares 10-Q · filed 2025-08-07 | 44.49M shares 10-Q · filed 2024-08-08 | 26.50M shares derived: average of 3 quarters · filed 2025-08-07 | 27.76M shares derived: average of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | 43.29M shares 10-Q · filed 2025-05-07 | 38.96M shares derived: average of 2 quarters · filed 2025-05-07 | 36.49M shares derived: average of 3 quarters · filed 2025-05-07 | 34.48M shares derived: average of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | 34.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 33.09M shares derived: average of 2 quarters · filed 2025-03-13 | 31.55M shares derived: average of 3 quarters · filed 2025-03-13 | 29.86M shares 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | 31.55M shares 10-Q · filed 2024-11-12 | 30.01M shares derived: average of 2 quarters · filed 2024-11-12 | 28.28M shares 10-Q · filed 2024-11-12 | 27.33M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 28.47M shares 10-Q · filed 2024-08-08 | 26.61M shares 10-Q · filed 2024-08-08 | 25.92M shares derived: average of 3 quarters · filed 2024-08-08 | 24.85M shares derived: average of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | 24.73M shares 10-Q · filed 2024-05-09 | 24.64M shares derived: average of 2 quarters · filed 2024-05-09 | 23.65M shares derived: average of 3 quarters · filed 2024-05-09 | 22.44M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 24.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 23.11M shares derived: average of 2 quarters · filed 2024-03-14 | 21.68M shares derived: average of 3 quarters · filed 2024-03-14 | 20.97M shares 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | 21.66M shares 10-Q · filed 2023-11-09 | 20.25M shares derived: average of 2 quarters · filed 2023-11-09 | 19.77M shares 10-Q · filed 2023-11-09 | 19.54M shares derived: average of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | 18.83M shares 10-Q · filed 2023-08-10 | 18.81M shares 10-Q · filed 2023-08-10 | 18.83M shares derived: average of 3 quarters · filed 2023-08-10 | 17.47M shares derived: average of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | 18.80M shares 10-Q · filed 2023-05-12 | 18.83M shares derived: average of 2 quarters · filed 2023-05-12 | 17.01M shares derived: average of 3 quarters · filed 2023-05-12 | 13.70M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 18.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 16.12M shares derived: average of 2 quarters · filed 2023-03-30 | 12.00M shares derived: average of 3 quarters · filed 2023-03-30 | 9.97M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 13.38M shares 10-Q · filed 2022-11-10 | 8.57M shares derived: average of 2 quarters · filed 2022-11-10 | 7.00M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 3.76M shares 10-Q · filed 2022-08-12 | 3.76M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |